Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1512.0
(-0.13%)
JPY 1512.0
(-0.13%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 7.78 Billion JPY | 65.52% |
| 2022 | 4.7 Billion JPY | 49.57% |
| 2021 | 3.14 Billion JPY | -34.29% |
| 2020 | 4.78 Billion JPY | -4.72% |
| 2019 | 5.02 Billion JPY | -20.22% |
| 2018 | 6.29 Billion JPY | -10.65% |
| 2017 | 7.04 Billion JPY | 0.9% |
| 2016 | 6.97 Billion JPY | 14.07% |
| 2015 | 6.11 Billion JPY | -12.96% |
| 2014 | 7.02 Billion JPY | 1.91% |
| 2013 | 6.89 Billion JPY | 30.92% |
| 2012 | 5.26 Billion JPY | -3.55% |
| 2011 | 5.46 Billion JPY | -13.37% |
| 2010 | 6.3 Billion JPY | -21.95% |
| 2009 | 8.07 Billion JPY | 7.01% |
| 2008 | 7.54 Billion JPY | 223.99% |
| 2007 | 2.33 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 7.1 Billion JPY | -8.66% |
| 2024 Q2 | 7.27 Billion JPY | 2.35% |
| 2023 FY | 7.78 Billion JPY | 65.52% |
| 2023 Q2 | 5.67 Billion JPY | 4.57% |
| 2023 Q4 | 7.78 Billion JPY | 9.98% |
| 2023 Q1 | 5.42 Billion JPY | 15.42% |
| 2023 Q3 | 7.07 Billion JPY | 24.69% |
| 2022 Q2 | 3.06 Billion JPY | 8.56% |
| 2022 Q1 | 2.82 Billion JPY | -10.05% |
| 2022 Q3 | 3.98 Billion JPY | 29.75% |
| 2022 FY | 4.7 Billion JPY | 49.57% |
| 2022 Q4 | 4.7 Billion JPY | 18.06% |
| 2021 Q3 | 3.93 Billion JPY | -2.19% |
| 2021 FY | 3.14 Billion JPY | -34.29% |
| 2021 Q1 | 4.26 Billion JPY | -10.83% |
| 2021 Q2 | 4.02 Billion JPY | -5.74% |
| 2021 Q4 | 3.14 Billion JPY | -20.07% |
| 2020 Q2 | 5.69 Billion JPY | 8.73% |
| 2020 Q1 | 5.23 Billion JPY | 4.26% |
| 2020 Q3 | 5.29 Billion JPY | -6.96% |
| 2020 FY | 4.78 Billion JPY | -4.72% |
| 2020 Q4 | 4.78 Billion JPY | -9.67% |
| 2019 Q1 | 6.1 Billion JPY | -2.92% |
| 2019 Q2 | 5.7 Billion JPY | -6.58% |
| 2019 FY | 5.02 Billion JPY | -20.22% |
| 2019 Q4 | 5.02 Billion JPY | -9.07% |
| 2019 Q3 | 5.52 Billion JPY | -3.24% |
| 2018 Q2 | 7.08 Billion JPY | 4.7% |
| 2018 Q3 | 6.9 Billion JPY | -2.5% |
| 2018 FY | 6.29 Billion JPY | -10.65% |
| 2018 Q4 | 6.29 Billion JPY | -8.92% |
| 2018 Q1 | 6.76 Billion JPY | -3.91% |
| 2017 Q1 | 6.7 Billion JPY | -3.94% |
| 2017 Q4 | 7.04 Billion JPY | -7.22% |
| 2017 Q3 | 7.59 Billion JPY | -7.25% |
| 2017 Q2 | 8.18 Billion JPY | 22.06% |
| 2017 FY | 7.04 Billion JPY | 0.9% |
| 2016 Q1 | 5.94 Billion JPY | -2.83% |
| 2016 Q4 | 6.97 Billion JPY | -14.81% |
| 2016 Q3 | 8.19 Billion JPY | 17.58% |
| 2016 Q2 | 6.96 Billion JPY | 17.19% |
| 2016 FY | 6.97 Billion JPY | 14.07% |
| 2015 Q3 | 7.99 Billion JPY | 7.21% |
| 2015 FY | 6.11 Billion JPY | -12.96% |
| 2015 Q4 | 6.11 Billion JPY | -23.5% |
| 2015 Q2 | 7.45 Billion JPY | -2.5% |
| 2015 Q1 | 7.65 Billion JPY | 8.83% |
| 2014 Q2 | 8.19 Billion JPY | 13.48% |
| 2014 Q4 | 7.02 Billion JPY | -18.37% |
| 2014 FY | 7.02 Billion JPY | 1.91% |
| 2014 Q3 | 8.61 Billion JPY | 5.04% |
| 2014 Q1 | 7.22 Billion JPY | 4.74% |
| 2013 Q2 | 5.09 Billion JPY | -2.21% |
| 2013 Q3 | 5.56 Billion JPY | 9.27% |
| 2013 Q4 | 6.89 Billion JPY | 23.96% |
| 2013 FY | 6.89 Billion JPY | 30.92% |
| 2013 Q1 | 5.2 Billion JPY | -1.16% |
| 2012 Q1 | 6.16 Billion JPY | 12.8% |
| 2012 Q3 | 6.53 Billion JPY | 9.16% |
| 2012 Q2 | 5.98 Billion JPY | -2.86% |
| 2012 FY | 5.26 Billion JPY | -3.55% |
| 2012 Q4 | 5.26 Billion JPY | -19.36% |
| 2011 Q1 | 6.85 Billion JPY | 8.79% |
| 2011 Q4 | 5.46 Billion JPY | -29.73% |
| 2011 FY | 5.46 Billion JPY | -13.37% |
| 2011 Q3 | 7.77 Billion JPY | 11.06% |
| 2011 Q2 | 6.99 Billion JPY | 2.04% |
| 2010 Q3 | 8.37 Billion JPY | 5.35% |
| 2010 Q4 | 6.3 Billion JPY | -24.68% |
| 2010 FY | 6.3 Billion JPY | -21.95% |
| 2010 Q1 | 8.12 Billion JPY | 0.52% |
| 2010 Q2 | 7.94 Billion JPY | -2.14% |
| 2009 Q2 | 7.04 Billion JPY | 0.0% |
| 2009 Q4 | 8.07 Billion JPY | -4.66% |
| 2009 Q3 | 8.47 Billion JPY | 20.24% |
| 2009 FY | 8.07 Billion JPY | 7.01% |
| 2008 Q3 | 7.27 Billion JPY | 0.0% |
| 2008 Q4 | 7.54 Billion JPY | 3.79% |
| 2008 FY | 7.54 Billion JPY | 223.99% |
| 2007 FY | 2.33 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | -535.184% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 99.823% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 98.004% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 102.246% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 318.315% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 118.458% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 112.657% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 107.945% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | 1266.567% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 115.015% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 123.635% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | -2.355% |
| Tsumura & Co. | 1.61 Billion JPY | -381.796% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 117.62% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 122.595% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 95.495% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 70.774% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 73.152% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | -10.212% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -1005.256% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | -29.856% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 219.395% |
| MedRx Co., Ltd | -1.72 Billion JPY | 552.384% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 189.268% |
| Solasia Pharma K.K. | -668 Million JPY | 1264.82% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | 628.983% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 207.28% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 86.234% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | 362.803% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 107.905% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 169.913% |